279 related articles for article (PubMed ID: 1484024)
1. "An analysis of epileptic patients nonresponsive to drugs".
Karande SC; Joshi MV; Kshirsagar NA; Shah PU
J Assoc Physicians India; 1992 Jul; 40(7):445-7. PubMed ID: 1484024
[TBL] [Abstract][Full Text] [Related]
2. [Decrease of folic acid and cognitive alterations in patients with epilepsy treated with phenytoin or carbamazepine, pilot study].
Hernández R; Fernández Mde L; Miranda G; Suástegui R
Rev Invest Clin; 2005; 57(4):522-31. PubMed ID: 16315636
[TBL] [Abstract][Full Text] [Related]
3. Therapeutic drug monitoring of antiepileptic drugs.
Shakya G; Malla S; Shakya KN; Shrestha R
JNMA J Nepal Med Assoc; 2008; 47(171):94-7. PubMed ID: 19079370
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of therapeutic drug level monitoring of phenobarbital, phenytoin and carbamazepine in Iranian epileptic patients.
Babaei A; Eslamai MH
Int J Clin Pharmacol Ther; 2007 Feb; 45(2):121-5. PubMed ID: 17323792
[TBL] [Abstract][Full Text] [Related]
5. Subtherapeutic levels of phenytoin with standard doses in infants: need to review dosage schedule.
Rane CT; Gogtay NJ; Kadam VS; Powar HS; Dalvi SS; Kshirsagar NA
Br J Clin Pharmacol; 1999 Sep; 48(3):465-6. PubMed ID: 10576792
[No Abstract] [Full Text] [Related]
6. Chronotherapeutic dose schedule of phenytoin and carbamazepine in epileptic patients.
Yegnanarayan R; Mahesh SD; Sangle S
Chronobiol Int; 2006; 23(5):1035-46. PubMed ID: 17050216
[TBL] [Abstract][Full Text] [Related]
7. Genetic predictors of the maximum doses patients receive during clinical use of the anti-epileptic drugs carbamazepine and phenytoin.
Tate SK; Depondt C; Sisodiya SM; Cavalleri GL; Schorge S; Soranzo N; Thom M; Sen A; Shorvon SD; Sander JW; Wood NW; Goldstein DB
Proc Natl Acad Sci U S A; 2005 Apr; 102(15):5507-12. PubMed ID: 15805193
[TBL] [Abstract][Full Text] [Related]
8. Therapeutic drug monitoring and clinical outcomes in epileptic Egyptian patients: a gene polymorphism perspective study.
Ebid AH; Ahmed MM; Mohammed SA
Ther Drug Monit; 2007 Jun; 29(3):305-12. PubMed ID: 17529887
[TBL] [Abstract][Full Text] [Related]
9. [Results of statistical analysis with a computer of the median effective dose and plasma levels of drugs in the treatment of epilepsy].
Oller L; Lagunas Hernandez MA; Russi Tintore A; Sabater Tobella J; Oller Daurella L
Arch Neurobiol (Madr); 1977; 40(1):37-46. PubMed ID: 856097
[No Abstract] [Full Text] [Related]
10. Antiepileptic TDM pattern at a tertiary care hospital in India.
Jose VM; Medhi B; Pandhi P
Nepal Med Coll J; 2006 Jun; 8(2):107-10. PubMed ID: 17017400
[TBL] [Abstract][Full Text] [Related]
11. [Anticonvulsive combined therapy (author's transl)].
Deisenhammer E; Sommer R; Nitsche V
Wien Klin Wochenschr; 1980 Jan; 92(1):23-4. PubMed ID: 6769255
[TBL] [Abstract][Full Text] [Related]
12. [Therapeutic surveillance of anti-epileptic drugs. Determination of dosage regimen and monitoring of treatment].
Kumps A
Acta Neurol Belg; 1982; 82(4):209-14. PubMed ID: 6814159
[No Abstract] [Full Text] [Related]
13. An audit of therapeutic drug monitoring of anticonvulsants.
Sharpe PC; Morrow J; Trimble ER
Ulster Med J; 1995 Oct; 64(2):151-6. PubMed ID: 8533181
[TBL] [Abstract][Full Text] [Related]
14. Serum aspirin-esterase activity in epileptic patients receiving treatment with phenobarbital, phenytoin, carbamazepine and valproic acid.
Puche E; Garcia de la Serrana H; Mota C; Saucedo R
Int J Clin Pharmacol Res; 1989; 9(1):55-8. PubMed ID: 2496043
[TBL] [Abstract][Full Text] [Related]
15. Prolonged use of phenytoin, carbamazepine or valproate monotherapy on plasma levels of folate and B(12): a comparison between epileptic patients with or without cardiovascular disorders.
Otoom S; Bakhiet M; Khan A; Sequeira R
Neuro Endocrinol Lett; 2006; 27(1-2):85-8. PubMed ID: 16648782
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of therapeutic drug monitoring of antiepileptic drugs.
Irshaid YM; Hamdi AA; Al Homrany M
Int J Clin Pharmacol Ther; 2003 Mar; 41(3):126-31. PubMed ID: 12665161
[TBL] [Abstract][Full Text] [Related]
17. [Differential treatment of epilepsy patients].
Karlov VA
Zh Nevropatol Psikhiatr Im S S Korsakova; 1980; 80(6):863-7. PubMed ID: 6774536
[TBL] [Abstract][Full Text] [Related]
18. [Optimisation of epilepsy monotherapy (clinico-pharmacological study)].
Gromov SA; Khorshev SK
Zh Nevrol Psikhiatr Im S S Korsakova; 1997; 97(7):31-5. PubMed ID: 9511212
[TBL] [Abstract][Full Text] [Related]
19. [Drug therapy of epilepsy with control of the serum level of anti-epileptic agents].
Fröscher W
Fortschr Med; 1979 Jun; 97(23):1073-6. PubMed ID: 456992
[No Abstract] [Full Text] [Related]
20. Serum protein binding of antiepileptic drugs in Sri Lankans.
Karunanayake EH; Joice PD; Peiris JB; Meijer JW; Meinardi H
Ceylon Med J; 1990 Mar; 35(1):25-8. PubMed ID: 2361227
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
